KELLY MICHAEL GERALD 4
4 · RENOVIS INC · Filed Nov 21, 2005
Insider Transaction Report
Form 4
RENOVIS INCRNVS
KELLY MICHAEL GERALD
VP, Drug Discovery
Transactions
- Sale
Common Stock
2005-11-17$13.64/sh−1,000$13,640→ 50,800 total
Footnotes (1)
- [F1]The sales that occurred on November 17, 2005 represent sales that should have occurred on June 16, 2005, July 18, 2005, August 16, 2005, September 16, 2005, October 17, 2005 and November 16, 2005 pursuant to Dr. Kelly's 10b5-1 Plan but did not occur because of broker error. In accordance with the broker's policy and procedures for correcting trade errors, a trade correction was executed on November 17, 2005.